EKSO

Q: What is the price of Ekso Bionics (EKSO) today?

The current price of Ekso Bionics (EKSO) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 8.64 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Ekso Bionics (EKSO) pay dividends?

Ekso Bionics (EKSO) did not pay dividends over the past year.

Q: Is Ekso Bionics (EKSO) a good investment?

Ekso Bionics (EKSO) is currently trading at $ 0.00 with a P/E ratio of -3.01. This represents a -220% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Ekso Bionics Holdings Inc.

Price

$ -

return (12m)

0.00%

p/e

-3.01

p/bv

8.22

DIVIDEND YIELD

0.00%

EKSO price

EKSO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment EKSO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals EKSO

review the fundamentals of Ekso Bionics shares

P/E

-3.01

Sector: -2.96 Industry: 0.83

P/S (PSR)

4.08

Sector: 1.86 Industry: 2.35

P/BV

8.22

Sector: 2.05 Industry: 2.29

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-79.72%

Sector: -29.54% Industry: -26.96%

ROE

-273.17%

Sector: -38.83% Industry: -37.23%

ROIC

-162.99%

Sector: -443.10% Industry: -95.45%

NET MARGIN

-100.00%

Sector: -31.47% Industry: -32.02%

GROSS MARGIN

52.81%

Sector: 43.63% Industry: 49.98%

OPERATING MARGIN

-100.00%

Sector: -26.60% Industry: -28.54%

EV/EBITDA

-3.45

Sector: -0.92 Industry: 0.70

EV/EBIT

-3.08

Sector: -2.65 Industry: -0.15

PRICE-TO-ASSETS

2.40

Sector: 1.11 Industry: 1.28

BVPS

1.44

Sector: 3.83 Industry: 5.06

EPS

-3.92

Sector: -1.01 Industry: -0.74

EQUITY-TO-ASSETS RATIO

0.29

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.71

Sector: 0.45 Industry: 0.50

CAGR REVENUE 5 YEARS

1,037.24%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

9.95%

Sector: - Industry: -

Fundamentals EKSO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	37.67	30.52	81.02%	0.59%	$ 952.11 B	34.99%
ISRG	52.21	8.84	16.93%	0.00%	$ 155.53 B	28.15%
SNY	7.24	1.29	17.79%	4.99%	$ 108.11 B	14.75%
TMO	24.35	3.20	13.15%	0.39%	$ 166.76 B	15.15%
NVS	21.44	7.45	34.77%	2.04%	$ 290.19 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.86	2.05	9.38%	3.61%	$ 100.84 B	13.00%
GSK	13.07	4.41	33.77%	3.44%	$ 102.50 B	17.79%
CVS	40.49	1.53	3.78%	2.85%	$ 118.72 B	0.72%
BSX	24.23	3.34	13.78%	0.00%	$ 86.38 B	17.29%
TMDX	13.63	4.74	34.80%	0.00%	$ 2.34 B	27.04%
HCA	12.99	-29.64	-228.14%	0.75%	$ 88.27 B	8.89%
IDXX	40.86	28.76	70.38%	0.00%	$ 44.75 B	24.63%
RMD	19.85	4.65	23.41%	1.12%	$ 30.17 B	27.44%
DHR	33.01	2.30	6.97%	0.79%	$ 121.78 B	14.89%
INMD	9.93	1.31	13.18%	0.00%	$ 865.62 M	23.27%
PHG	21.85	1.87	8.56%	3.42%	$ 24.68 B	5.50%
SYK	36.22	5.26	14.52%	1.09%	$ 120.87 B	13.21%
FMS	10.81	0.72	6.71%	3.64%	$ 11.90 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

EKSO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ekso Bionics

Ekso Bionics Holdings Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2013

Time since IPO - 13 years

40

Employees

Ekso Bionics Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $47.20 Trillions, with shareholders equity totaling $5.74 Millions.

The company employs approximately 40 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Ekso Bionics Holdings Inc. reported $11.57 Millions in revenue, generating net income of $-15.68 Millions.

Key financial metrics include a P/E ratio of -3.01, a price-to-book (P/B) ratio of 8.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EKSO.

Market cap

$ 47.20 Trillions

Net worth

$ 5.74 Millions

$ 5,740,000.00

Assets

$ 19.67 Millions

$ 19,670,000.00

Total Shares Outstanding

4.00 Millions

4,000,000

Average Daily Trading Volume

$ 69.32 Thousand

$ 69,317.64

Sector

Health

Industry

Medical Supplies and Equipment

EKSO

EKSO revenue and profits

Financial Results EKSO

DRAG THE FRAME TO SEE MORE DATA

EKSO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 93.26 58,90% (12M)

P/E

40.49

2.85%

ROE

3.78%

P/BV

1.53

CI - Cigna

$ 286.24 --7,51% (12M)

P/E

11.64

2.13%

ROE

15.39%

P/BV

1.79

CNC - Centene

$ 59.14 4,84% (12M)

P/E

-4.52

0.00%

ROE

-29.93%

P/BV

1.35

HUM - Humana

$ 307.95 39,06% (12M)

P/E

32.70

1.15%

ROE

6.06%

P/BV

1.98

SNY - Sanofi

$ 44.29 --11,03% (12M)

P/E

7.24

4.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,065.00 47,95% (12M)

P/E

37.67

0.59%

ROE

81.02%

P/BV

30.52

HCA - HCA Healthcare

$ 394.07 5,54% (12M)

P/E

12.99

0.75%

ROE

-228.14%

P/BV

-29.64

NVS - Novartis

$ 152.01 37,44% (12M)

P/E

21.44

2.04%

ROE

34.77%

P/BV

7.45